fda bans compounded tirzepatide Ban on GLP-1 Drugs: What to Know Is Compounded Tirzepatide Safe or

Select your treatment Choose a plan that fits your needs and complete a medical intake form for review by providers

GIP receptor activation enhances insulin secretion, modulates adipose tissue metabolism, and appears to synergise with GLP-1 activity to produce greater metabolic effects than either hormone alone as demonstrated by the clinical performance of the dual agonist tirzepatide

While carnitine supplementation may offer benefits, it is not without risks, particularly for individuals with certain psychiatric conditions

We will work with you to discuss your needs and develop and individualized treatment plan